In HCC patients, a meta-analysis demonstrated that a high sPD-L1 level correlates with a shorter survival (HR: 2.93; 95% CI: 2.20–3.91; p < 0.00001) [36]. The gene discussed is SPDL1; the disease is hepatocellular carcinoma.